The pharmacokinetics and dosing of oral 4‐methylumbelliferone for inhibition of hyaluronan synthesis in mice

Recently, there has been considerable interest in using 4‐methylumbelliferone (4‐MU) to inhibit hyaluronan (HA) synthesis in mouse models of cancer, autoimmunity and a variety of other inflammatory disorders where HA has been implicated in disease pathogenesis. In order to facilitate future studies...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Exp Immunol
Main Authors: Kuipers, H. F., Nagy, N., Ruppert, S. M., Sunkari, V. G., Marshall, P. L., Gebe, J. A., Ishak, H. D., Keswani, S. G., Bollyky, J., Frymoyer, A. R., Wight, T. N., Steinman, L., Bollyky, P. L.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991518/
https://ncbi.nlm.nih.gov/pubmed/27218304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12815
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki